Načítá se...
Development of a miRNA-seq based prognostic signature in lung adenocarcinoma
BACKGROUND: We utilized miRNAs expression and clinical data to develop a prognostic signature for patients with lung adenocarcinoma, with respect to their overall survival, to identify high-risk subjects based on their miRNA genomic profile. METHODS: MiRNA expressions based on miRNA sequencing and c...
Uloženo v:
| Vydáno v: | BMC Cancer |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6325795/ https://ncbi.nlm.nih.gov/pubmed/30621620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5206-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|